{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T03:03:49Z","timestamp":1768705429111,"version":"3.49.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Liquids"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.molliq.2024.126654","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:44:25Z","timestamp":1733445865000},"page":"126654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Novel fluoroquinolone-based organic salts: Pioneering solutions in targeting bacterial DNA gyrase"],"prefix":"10.1016","volume":"417","author":[{"given":"F\u00e1bio M.S.","family":"Costa","sequence":"first","affiliation":[]},{"given":"M. L\u00facia M.F.S.","family":"Saraiva","sequence":"additional","affiliation":[]},{"given":"Marieta L.C.","family":"Passos","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.molliq.2024.126654_b0005","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.molliq.2024.126654_b0010","unstructured":"European Centre for Disease Prevention and Control, Assessing the health burden of infections with antibiotic-resistant bacteria in the EU\/EEA, 2016-2020, in: ECDC (Ed.), ECDC, Stockholm, 2022."},{"key":"10.1016\/j.molliq.2024.126654_b0015","doi-asserted-by":"crossref","unstructured":"U.S. Centers for Disease Control and Prevention, Antibiotic Resistance Threats in the United States, in: CDC (Ed.), U.S. Department of Health and Human Services, Atlanta, GA, 2019. Doi: 10.15620\/cdc:82532.","DOI":"10.15620\/cdc:82532"},{"key":"10.1016\/j.molliq.2024.126654_b0020","unstructured":"European Centre for Disease Prevention and Control, Antimicrobial consumption in the EU-EEA (EARS-Net) Annual Epidemiological Report for 2022, in: ECDC (Ed.), ECDC, Stockholm, 2023."},{"key":"10.1016\/j.molliq.2024.126654_b0025","article-title":"Antimicrobial resistance: a growing serious threat for global public health","volume":"11","author":"Salam","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.molliq.2024.126654_b0030","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol."},{"key":"10.1016\/j.molliq.2024.126654_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10101310","article-title":"Bacterial antibiotic resistance: the most critical pathogens","volume":"10","author":"Mancuso","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.molliq.2024.126654_b0040","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"Medchemcomm"},{"issue":"Suppl 3","key":"10.1016\/j.molliq.2024.126654_b0045","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/321846","article-title":"Quinolone molecular structure-activity relationships: what we have learned about improving antimicrobial activity","volume":"33","author":"Peterson","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molliq.2024.126654_b0050","series-title":"World Health Organization model list of essential medicines: 23rd list","first-page":"1","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.molliq.2024.126654_b0055","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.molliq.2024.126654_b0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2202","article-title":"Multi-targeting by monotherapeutic antibacterials","volume":"6","author":"Silver","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molliq.2024.126654_b0065","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1568026613666131113153251","article-title":"Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases","volume":"14","author":"Tomasic","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.molliq.2024.126654_b0070","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.biopha.2018.04.021","article-title":"DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents","volume":"103","author":"Khan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.molliq.2024.126654_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020371","article-title":"DNA gyrase as a target for quinolones","volume":"11","author":"Spencer","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.molliq.2024.126654_b0080","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1128\/AAC.38.11.2623","article-title":"Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition","volume":"38","author":"Hoshino","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0085","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jac\/dkn528","article-title":"Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli","volume":"63","author":"Cambau","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0090","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1128\/AAC.00496-08","article-title":"Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases","volume":"52","author":"Black","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.molliq.2024.126654_b0100","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.molliq.2024.126654_b0105","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","article-title":"Exploiting bacterial DNA gyrase as a drug target: current state and perspectives","volume":"92","author":"Collin","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.molliq.2024.126654_b0110","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1073\/pnas.1102100108","article-title":"DNA-induced narrowing of the gyrase N-gate coordinates T-segment capture and strand passage","volume":"108","author":"Gubaev","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.molliq.2024.126654_b0115","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1021\/cr4003984","article-title":"Non-quinolone inhibitors of bacterial type IIA topoisomerases: a feat of bioisosterism","volume":"114","author":"Mayer","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molliq.2024.126654_b0120","doi-asserted-by":"crossref","first-page":"7184","DOI":"10.1021\/ac501529m","article-title":"Perspectives on moving ionic liquid chemistry into the solid phase","volume":"86","author":"Warner","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.molliq.2024.126654_b0125","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3389\/fchem.2019.00347","article-title":"Proteins in ionic liquids: reactions, applications, and futures","volume":"7","author":"Schindl","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.molliq.2024.126654_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.598662","article-title":"Use of ionic liquids in protein and DNA chemistry","volume":"8","author":"Shukla","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.molliq.2024.126654_b0135","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijbiomac.2012.06.020","article-title":"Effect of ionic liquid on activity, stability, and structure of enzymes: a review","volume":"51","author":"Naushad","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.molliq.2024.126654_b0140","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bej.2015.03.005","article-title":"Key factors affecting the activity and stability of enzymes in ionic liquids and novel applications in biocatalysis","volume":"99","author":"Gao","year":"2015","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.molliq.2024.126654_b0145","series-title":"Group of Uniform Materials Based on Organic Salts (GUMBOS): A Review of Their Solid State Properties and Applications","author":"P\u00e9rez","year":"2021"},{"key":"10.1016\/j.molliq.2024.126654_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.120750","article-title":"Ionic liquids and organic salts with antimicrobial activity as a strategy against resistant microorganisms","volume":"368","author":"Costa","year":"2022","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.molliq.2024.126654_b0155","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.3390\/molecules20046466","article-title":"Recycling antibiotics into GUMBOS: a new combination strategy to combat multi-drug-resistant bacteria","volume":"20","author":"Cole","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.molliq.2024.126654_b0160","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/jac\/dkaa346","article-title":"Octenidine\/carbenicillin GUMBOS as potential treatment for oropharyngeal gonorrhoea","volume":"75","author":"Lopez","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0165","article-title":"Antibiotics modified by hydrophobic ion-pairing \u2013 A solution world's problems with resistant bacteria?","volume":"37","author":"Kwiecie\u0144","year":"2023","journal-title":"Sustain. Mater. Technol."},{"key":"10.1016\/j.molliq.2024.126654_b0170","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/cmdc.201700549","article-title":"Synthesis and evaluation of N-phenylpyrrolamides as DNA gyrase B inhibitors","volume":"13","author":"Durcik","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molliq.2024.126654_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115714","article-title":"Fluoroquinolone-based organic salts (GUMBOS) with antibacterial potential","volume":"24","author":"Costa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molliq.2024.126654_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116261","article-title":"The effect of conjugation of ciprofloxacin and moxifloxacin with fatty acids on their antibacterial and anticancer activity","volume":"23","author":"Chrzanowska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl B","key":"10.1016\/j.molliq.2024.126654_b0185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/43.suppl_2.31","article-title":"The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus","volume":"43","author":"Schedletzky","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0190","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":"Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics","volume":"133","author":"Mather","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.molliq.2024.126654_b0195","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0002-9394(03)00294-0","article-title":"Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates","volume":"136","author":"Kowalski","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.molliq.2024.126654_b0200","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/AAC.48.6.1948-1952.2004","article-title":"Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis","volume":"48","author":"Dajcs","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0205","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/jac\/43.6.833","article-title":"Comparative in-vitro activity of moxifloxacin, penicillin, ceftriaxone and ciprofloxacin against pneumococci isolated from meningitis","volume":"43","author":"Tarasi","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0210","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/AAC.48.3.946-953.2004","article-title":"Activities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model","volume":"48","author":"Ba","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156690","article-title":"Comparative activity of ciprofloxacin, levofloxacin and moxifloxacin against klebsiella pneumoniae, pseudomonas aeruginosa and stenotrophomonas maltophilia assessed by minimum inhibitory concentrations and time-kill studies","volume":"11","author":"Grillon","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.molliq.2024.126654_b0220","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1128\/AAC.44.8.2211-2213.2000","article-title":"Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains","volume":"44","author":"Heinemann","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0225","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0924-8579(02)00209-1","article-title":"Antianaerobic activity of moxifloxacin compared with that of ofloxacin, ciprofloxacin, clindamycin, metronidazole and beta-lactams","volume":"20","author":"Behra-Miellet","year":"2002","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.molliq.2024.126654_b0230","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jac\/44.5.621","article-title":"Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin","volume":"44","author":"Pong","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0235","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1128\/AAC.34.6.1088","article-title":"Mechanism of action of lomefloxacin","volume":"34","author":"Piddock","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0240","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.1016\/0732-8893(89)90062-X","article-title":"Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens","volume":"12","author":"Stratton","year":"1989","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.molliq.2024.126654_b0245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/25.1.91","article-title":"Lomefloxacin-induced modification of the kinetics of growth of gram-negative bacteria and susceptibility to phagocytic killing by human neutrophils","volume":"25","author":"Pruul","year":"1990","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.molliq.2024.126654_b0250","doi-asserted-by":"crossref","first-page":"11153","DOI":"10.3390\/molecules180911153","article-title":"Metal complexes of quinolone antibiotics and their applications: an update","volume":"18","author":"Uivarosi","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.molliq.2024.126654_b0255","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00254-20","article-title":"Sodium tetraphenylborate displays selective bactericidal activity against Neisseria meningitidis and N. Gonorrhoeae and is effective at reducing bacterial infection load","volume":"65","author":"Bernet","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.molliq.2024.126654_b0260","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jbiotec.2009.04.011","article-title":"Hofmeister effects: an explanation for the impact of ionic liquids on biocatalysis","volume":"144","author":"Yang","year":"2009","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.molliq.2024.126654_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.121240","article-title":"An automatic approach for the evaluation of the effect of ionic liquids and deep eutectic solvents on elastase","volume":"373","author":"Passos","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.molliq.2024.126654_b0270","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","article-title":"The interaction between bacteria and bile","volume":"29","author":"Begley","year":"2005","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.molliq.2024.126654_b0275","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10930-011-9360-y","article-title":"Bile acids as modulators of enzyme activity and stability","volume":"30","author":"Robic","year":"2011","journal-title":"Protein J."},{"key":"10.1016\/j.molliq.2024.126654_b0280","doi-asserted-by":"crossref","first-page":"E1610","DOI":"10.1073\/pnas.1401941111","article-title":"Bile salts act as effective protein-unfolding agents and instigators of disulfide stress in vivo","volume":"111","author":"Cremers","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.molliq.2024.126654_b0285","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fmed.2017.00163","article-title":"Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts","volume":"4","author":"Urdaneta","year":"2017","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.molliq.2024.126654_b0290","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/CMR.00031-16","article-title":"Survival of the fittest: how bacterial pathogens utilize bile to enhance infection","volume":"29","author":"Sistrunk","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.molliq.2024.126654_b0295","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1128\/aem.53.8.1944-1946.1987","article-title":"The action of sodium deoxycholate on Escherichia coli","volume":"53","author":"D'Mello","year":"1987","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.molliq.2024.126654_b0300","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.molcatb.2007.11.010","article-title":"Design of phosphonium ionic liquids for lipase-catalyzed transesterification","volume":"51","author":"Abe","year":"2008","journal-title":"J. Mol. Catal. B Enzym."},{"key":"10.1016\/j.molliq.2024.126654_b0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijbiomac.2013.10.031","article-title":"Does the stability of proteins in ionic liquids obey the Hofmeister series?","volume":"63","author":"Kumar","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.molliq.2024.126654_b0310","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jctb.4837","article-title":"Protein stabilization and enzyme activation in ionic liquids: specific ion effects","volume":"91","author":"Zhao","year":"2016","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"10.1016\/j.molliq.2024.126654_b0315","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1002\/anie.200702295","article-title":"Protein denaturation by ionic liquids and the Hofmeister series: a case study of aqueous solutions of ribonuclease A","volume":"46","author":"Constantinescu","year":"2007","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.molliq.2024.126654_b0320","doi-asserted-by":"crossref","DOI":"10.21767\/2573-4466.100012","article-title":"Biocatalytic activity of mushroom tyrosinase in ionic liquids: specific ion effects and the hofmeister series","volume":"02","author":"Heitz","year":"2018","journal-title":"Insights Enzyme Res."},{"key":"10.1016\/j.molliq.2024.126654_b0325","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/bm049259q","article-title":"Understanding structure-stability relationships of Candida antartica lipase B in ionic liquids","volume":"6","author":"De Diego","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.molliq.2024.126654_b0330","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcatb.2006.11.008","article-title":"Using ionic liquids to stabilize lipase within sol\u2013gel derived silica","volume":"45","author":"Lee","year":"2007","journal-title":"J. Mol. Catal. B Enzym."},{"key":"10.1016\/j.molliq.2024.126654_b0335","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/jctb.2375","article-title":"Methods for stabilizing and activating enzymes in ionic liquids\u2014a review","volume":"85","author":"Zhao","year":"2010","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"10.1016\/j.molliq.2024.126654_b0340","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1021\/cr050946x","article-title":"Biocatalysis in ionic liquids","volume":"107","author":"van Rantwijk","year":"2007","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molliq.2024.126654_b0345","first-page":"3744","article-title":"Hydrolysis of tetrafluoroborate and hexafluorophosphate counter ions in imidazolium-based ionic liquids","volume":"114","author":"Freire","year":"2010","journal-title":"Chem. A Eur. J."},{"key":"10.1016\/j.molliq.2024.126654_b0350","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.chemosphere.2010.11.046","article-title":"Automated evaluation of the effect of ionic liquids on catalase activity","volume":"82","author":"Pinto","year":"2011","journal-title":"Chemosphere"},{"key":"10.1016\/j.molliq.2024.126654_b0355","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cogsc.2019.05.004","article-title":"Water\u2014the greenest solvent overall","volume":"18","author":"Zhou","year":"2019","journal-title":"Current Opinion Green Sustainable Chem."},{"key":"10.1016\/j.molliq.2024.126654_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/ph15121507","article-title":"Water as green solvent: methods of solubilisation and extraction of natural products-past, present and future solutions","volume":"15","author":"Lajoie","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.molliq.2024.126654_b0365","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jiec.2019.05.023","article-title":"Synthesis, properties and adjuvant activity of docusate-based ionic liquids in pesticide formulations","volume":"78","author":"Kaczmarek","year":"2019","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.molliq.2024.126654_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2020.03.016","article-title":"About the impact of superassociation of hydrophobic ion pairs on membrane permeability","volume":"151","author":"Shahzadi","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.molliq.2024.126654_b0375","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ultsonch.2017.08.034","article-title":"Extraction of consortium of hydrolytic enzymes from waste activated sludge using ultrasonication and stirring with surfactants","volume":"40","author":"Anbazhagan","year":"2018","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.molliq.2024.126654_b0380","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1021\/acsinfecdis.1c00063","article-title":"Docusate-based ionic liquids of anthelmintic benzimidazoles show improved pharmaceutical processability lipid solubility, and in vitro activity against cryptococcus neoformans","volume":"7","author":"Sutar","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.molliq.2024.126654_b0385","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.matchemphys.2012.09.042","article-title":"Preparation and antibacterial properties of hybrid-zirconia films with silver nanoparticles","volume":"137","author":"Az\u00f3car","year":"2012","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.molliq.2024.126654_b0390","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-015-0131-3","article-title":"Effects of various heavy metal nanoparticles on Enterococcus hirae and Escherichia coli growth and proton-coupled membrane transport","volume":"13","author":"Vardanyan","year":"2015","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.molliq.2024.126654_b0395","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cmdc.201900607","article-title":"Dual Escherichia coli DNA Gyrase A and B inhibitors with antibacterial activity","volume":"15","author":"Fois","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.molliq.2024.126654_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010006","article-title":"Hybrid inhibitors of DNA Gyrase A and B: design, synthesis and evaluation","volume":"13","author":"Durcik","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.molliq.2024.126654_b0405","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/ph14050399","article-title":"Design, synthesis, and antibacterial screening of some novel heteroaryl-based ciprofloxacin derivatives as DNA gyrase and topoisomerase IV inhibitors","volume":"14","author":"Al-Wahaibi","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.molliq.2024.126654_b0410","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejmech.2013.08.040","article-title":"Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity","volume":"69","author":"Abdel-Aziz","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.molliq.2024.126654_b0415","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s11030-022-10528-z","article-title":"Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors","volume":"27","author":"Mohammed","year":"2023","journal-title":"Mol. Divers."},{"key":"10.1016\/j.molliq.2024.126654_b0420","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900086","article-title":"Synthesis, antibacterial evaluation, and DNA gyrase inhibition profile of some new quinoline hybrids","volume":"352","author":"Rizk","year":"2019","journal-title":"Arch Pharm. (Weinheim)"},{"key":"10.1016\/j.molliq.2024.126654_b0425","article-title":"Key factors in effective patient-tailored dosing of fluoroquinolones in urological infections: interindividual pharmacokinetic and pharmacodynamic variability","volume":"11","author":"Estrade","year":"2022","journal-title":"Antibiotics (Basel)"}],"container-title":["Journal of Molecular Liquids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167732224027156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167732224027156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T09:04:38Z","timestamp":1735376678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167732224027156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":85,"alternative-id":["S0167732224027156"],"URL":"https:\/\/doi.org\/10.1016\/j.molliq.2024.126654","relation":{},"ISSN":["0167-7322"],"issn-type":[{"value":"0167-7322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel fluoroquinolone-based organic salts: Pioneering solutions in targeting bacterial DNA gyrase","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Liquids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molliq.2024.126654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"126654"}}